Indian American neuroscientist Dr. Shyamala (Sarvepalli) Mruthinti has been named a recipient of the Women Researcher Award – Scientific Laurels, recognizing her contributions to Alzheimer’s disease research, immunology, biotechnology innovation and scientific education.
With a career spanning more than four decades, Mruthinti has worked across biomedical research, higher education and biotechnology entrepreneurship.
Research into Alzheimer’s disease
Mruthinti served as an assistant professor and director of the Monoclonal Antibody Core Facility at the Medical College of Georgia from 1990 to 1996. She subsequently joined the Augusta VA Medical Center, where she worked from 1996 to 2012 as a research pharmacologist, principal investigator and Alzheimer’s research project manager.
Her Alzheimer’s research explored how certain proteins and immune responses may contribute to the disease, including their potential relationship with dementia severity and cognitive decline.
As principal investigator, she secured a three-year VA Merit Review Grant initially valued at $650,000. She also received a $100,000 VISN-7 Career Development Award.
Patents and biotechnology innovation
Mruthinti was a named inventor on U.S. Patent Application Publication No. US20100297160A1, describing an experimental oral vaccine concept involving amyloid-beta and vaccine antigens.
Her research also contributed to the development of RD9C2, a monoclonal antibody targeting RAGE, a receptor involved in Alzheimer’s-related research, that was subsequently commercialized for research applications.
Beyond academic research, she was a founding partner and antibody production manager at Immuno-Rx Inc. and later served as president and CEO of Datta ImmunoChem Inc.
Academic leadership and international recognition
Mruthinti has supervised research laboratories, mentored doctoral and medical trainees, and contributed to scientific publications addressing neurodegeneration, immunology, monoclonal antibodies and cancer. Her research has appeared in journals including Neurobiology of Aging, Neuroscience, Current Alzheimer Research and the Journal of Molecular Neuroscience.
Her academic qualifications include a Ph.D. and an M.Sc. in Botany from Maharaja Sayajirao University of Baroda, an M.A. in Philosophy, and a B.Sc. in Botany, Chemistry and Zoology from Osmania University.
In December 2025, she delivered a keynote address at an international biotechnology conference at Osmania University, where she was recognized with a Best Technologist Innovators for Sustainable Development award.
Her other reported honors include the Albert Nelson Marquis Lifetime Achievement Award.
Alongside her scientific work, Mruthinti has pursued interdisciplinary interests in brain health, healthy aging, consciousness and mind-body well-being. She has completed a manuscript titled Better Understanding of Alzheimer’s: From a Holistic View of the Brain–Mind–Consciousness.
Her two upcoming books, Better Understanding of Alzheimer’s: From a Holistic View of the Brain–Mind–Consciousness and The Science of Being and Becoming: From Particles, Matter, Mind to Universal Consciousness, explore Alzheimer’s disease, brain health and the relationship between science and consciousness.